BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20191016T103000
DTEND;TZID=Europe/London:20191016T163000
DTSTAMP:20260410T121428
CREATED:20190715T095440Z
LAST-MODIFIED:20190715T095440Z
UID:17990-1571221800-1571243400@staging.medilinkmidlands.com
SUMMARY:EU MDR Clinical Strategy & Evidence Requirements for CE Marking Workshop - 16 Oct\, London
DESCRIPTION:Wednesday 16th October 2019 \nHill Dickinson\, Broadgate Tower\, 20 Primrose Street\, London EC2A 2EW\, 10:30 – 16:00 \nSEHTA members fee – £250 + VAT per delegate  \nSEHTA non-members fee – £300 + VAT per delegate \nWhy attend \nClinical strategy\, evidence and evaluation are central to product approval and market access. \nThrough clinical data a company is able to ensure: \n  \n\nthat their medical device is able to obtain CE Marking and other regulatory approvals;\nthat the device performs clinically in both a safe and effective manner per the intended use and in the indicated patient population; and\nthat they are able to place it on the market supported by sufficient clinical evidence for user adoption and reimbursement.\n\n  \nIt is a requirement of the new EU Medical Device Regulation that a medical device company have a regulatory strategy and of the MDR and MEDDEV 2.7/1 rev 4 that the company have a clinical evaluation strategy. \nIn order to effectively market their device and generate sales\, organisations need to have considered well in advance the clinical elements for market access as failure to do so may put them back months\, through not understanding and obtaining appropriate data when initially gathering clinical evidence. \nNotified Bodies and regulatory authorities are placing greater emphasis on clinical evidence. Competent Authorities & regulators in other countries are also looking at clinical data and expecting up to date evidence. In addition\, purchasers of devices are increasing their requirements for clinical evidence that demonstrates good clinical outcomes and value (evidence-based medicine). The need for clinical evidence and evaluation is a core theme and needs to be captured to satisfy regulators\, notified bodies\, patients\, physicians\, procurement\, reimbursement agencies (e.g. NICE)\, etc. \nCompanies need to be prepared and have solutions in place to address this and their ongoing clinical requirements. Getting your clinical strategy wrong will delay approval and also market access. \nPlease note this is for Medical Device firms only – not Pharma or IVD \n  \nThis one-day workshop will give you: \n  \n\nAn overview of the new EU Medical Device CE Marking Process\nHelp you to maintain Access to the Market\nUnderstand the key areas of compliance required\nUnderstand the technical documentation that should be in place for each device\nGain a plan of action for implementation and CE Marking under the new legislation\n\n  \nTarget Market: C suite\, executives\, product owners\, medical officers\, regulatory and clinical specialists within a company that need to understand the overall clinical requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nTo view an agenda for this event\, click here \nTo register for this event\, click here
URL:https://staging.medilinkmidlands.com/event/eu-mdr-clinical-strategy-evidence-requirements-for-ce-marking-workshop-16-oct-london/
LOCATION:Hill Dickinson\, Broadgate Tower\, 20 Primrose Street\, London\, EC2A 2EW
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
END:VCALENDAR